Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS
Medical Groups Express Concern to Becerra Over ACO Reporting Requirements
In a letter to HHS Secretary Xavier Becerra, a dozen medical groups and healthcare organizations called upon the Biden…
HHS Releases New Buprenorphine Practice Guidelines
Recently, the United States Department of Health and Human Services (HHS) released new buprenorphine practice guidelines, Practice…
What Does Secretary Becerra Mean for Drug Prices?
In March, the U.S. Senate voted to confirm Xavier Becerra as secretary of the Department of Health and Human Services despite…
HHS Releases Notice of Benefit and Payment Parameters for 2022, Part Two
Recently, the United States Department of Health and Human Services (HHS) released the Notice of Benefit and Payment Parameters…
HHS Postpones Implementation of the SUNSET Rule
The US Department of Health and Human Services (HHS) postponed the implementation of a controversial Trump era rule that would…
Telemedicine Fraud Catches the Eye of HHS OIG
With the rise in telemedicine around the United States, the federal government is increasingly looking at telehealth-related…
PBM Rebate Rule Effective Date Postponed
Readers may remember the Part D rebate final rule finalized by Health and Human Services (HHS) late last year. After the rule was…
Drug Manufacturers Sue HHS Over 340B Advisory Opinion
Three drug companies have filed separate lawsuits to preserve their ability to restrict offerings of 340B-discounted drugs to…
Price Transparency Rule Given the Green Light by D.C. Court of Appeals
On December 29, 2020, the United States Court of Appeals for the District of Columbia Circuit upheld the Centers for Medicare and…
Trump Administration Makes Final Proposed Rule Push
Two proposed rules from the last few weeks of the Trump administration may be of note to some of our readers. The first addresses…